Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2026-01-01 @ 3:07 PM
Study NCT ID:
NCT05113966
Status:
TERMINATED
Last Update Posted:
2025-01-29
First Post:
2021-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Sponsor:
G1 Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-18
First Submit QC Date:
None
Study First Post Date:
2021-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-05
Results First Submit QC Date:
None
Results First Post Date:
2025-01-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-06
Last Update Post Date:
2025-01-29
Last Update Post Date Type:
ACTUAL